Hualan Biological Bacterin Inc.’s Net Profit Dropped 63.7% in First Half of 2023

Hualan Biological Bacterin Inc. (华兰生物疫苗股份有限公司) (301207.SZ) reported a net profit of 108.2 million yuan in the first half of 2023, down 63.7% year-on-year.

Meanwhile, the company posted 149.6 million yuan in revenue, down 85.9% year-on-year.

At the end of the reporting period, it had 6.8 billion yuan in total assets and 1.3 billion yuan in total liabilities, with a liability-to-asset ratio of 19%.